ANI Pharmaceuticals Inc (NASDAQ:ANIP) — Market Cap & Net Worth

$1.65 Billion USD · Rank #6884

Market Cap & Net Worth: ANI Pharmaceuticals Inc (ANIP)

ANI Pharmaceuticals Inc (NASDAQ:ANIP) has a market capitalization of $1.65 Billion ($1.65 Billion) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #6884 globally and #2133 in its home market, demonstrating a 4.78% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying ANI Pharmaceuticals Inc's stock price $73.59 by its total outstanding shares 22414104 (22.41 Million). Also see ANIP total asset value for a full breakdown of the balance sheet.

ANI Pharmaceuticals Inc Market Cap History: 2015 to 2026

ANI Pharmaceuticals Inc's market capitalization history from 2015 to 2026. Data shows growth from $1.01 Billion to $1.65 Billion (5.31% CAGR). Also see ANIP operating cash flow for how efficiently the company converts equity into cash flow.

Index Memberships

ANI Pharmaceuticals Inc is a constituent of 4 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NASDAQ Health Care IXHC	$2.66 Trillion	0.06%	#199 of 976
NASDAQ Composite IXIC	$41.69 Trillion	0.00%	#776 of 3165
NASDAQ Biotechnology NBI	$1.88 Trillion	0.09%	#118 of 263
S&P Small-Cap 600 Index SML	$1.61 Trillion	0.09%	#370 of 602

Weight: ANI Pharmaceuticals Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

ANI Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how ANI Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for ANI Pharmaceuticals Inc for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

2.00x

ANI Pharmaceuticals Inc's market cap is 2.00 times its annual revenue

Industry average: 0.57x Higher than industry average

Latest Price to Earnings (P/E) Ratio

22.59x

ANI Pharmaceuticals Inc's market cap is 22.59 times its annual earnings

Industry average: 2.01x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$1.36 Billion	$128.62 Million	$3.93 Million	10.56x	345.38x
2017	$1.44 Billion	$176.84 Million	-$1.08 Million	8.17x	N/A
2018	$1.01 Billion	$201.58 Million	$15.49 Million	5.01x	65.13x
2019	$1.38 Billion	$206.55 Million	$6.09 Million	6.69x	226.83x
2020	$650.91 Million	$208.47 Million	-$22.55 Million	3.12x	N/A
2021	$1.03 Billion	$216.14 Million	-$42.60 Million	4.78x	N/A
2022	$901.72 Million	$316.38 Million	-$47.90 Million	2.85x	N/A
2023	$1.24 Billion	$486.82 Million	$18.78 Million	2.54x	65.81x
2024	$1.24 Billion	$614.38 Million	-$18.52 Million	2.02x	N/A
2025	$1.77 Billion	$883.37 Million	$78.34 Million	2.00x	22.59x

Competitor Companies of ANIP by Market Capitalization

Companies near ANI Pharmaceuticals Inc in the global market cap rankings as of September 18, 2026. Review ANI Pharmaceuticals Inc (ANIP) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.

Key companies related to ANI Pharmaceuticals Inc by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #519 globally with a market cap of $52.60 Billion USD.
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #633 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
GALDERMA GROUP AG (NYSE:GALDY): Ranked #640 globally with a market cap of $43.16 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.62 Billion USD ( CN¥277.61 Billion CNY).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#519	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#633	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€16.00
#640	GALDERMA GROUP AG	NYSE:GALDY	$43.16 Billion	$37.02
#670	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$40.62 Billion	CN¥43.52

ANI Pharmaceuticals Inc Historical Marketcap From 2015 to 2026

Between 2015 and today, ANI Pharmaceuticals Inc's market cap moved from $1.01 Billion to $ 1.65 Billion, with a yearly change of 5.31%.

Year	Market Cap	Change (%)
2026	$1.65 Billion	-6.78%
2025	$1.77 Billion	+42.80%
2024	$1.24 Billion	+0.25%
2023	$1.24 Billion	+37.06%
2022	$901.72 Million	-12.70%
2021	$1.03 Billion	+58.68%
2020	$650.91 Million	-52.91%
2019	$1.38 Billion	+36.98%
2018	$1.01 Billion	-30.15%
2017	$1.44 Billion	+6.32%
2016	$1.36 Billion	+34.34%
2015	$1.01 Billion	--

End of Day Market Cap According to Different Sources

On Sep 17th, 2026 the market cap of ANI Pharmaceuticals Inc was reported to be:

Source	Market Cap
Yahoo Finance	$1.65 Billion USD
MoneyControl	$1.65 Billion USD
MarketWatch	$1.65 Billion USD
marketcap.company	$1.65 Billion USD
Reuters	$1.65 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About ANI Pharmaceuticals Inc

NASDAQ:ANIP USA Drug Manufacturers - Specialty & Generic

Market Cap

$1.65 Billion

Market Cap Rank

#6884 Global

#2133 in USA

Share Price

$73.59

Change (1 day)

+2.05%

52-Week Range

$70.19 - $97.48

All Time High

$98.81